THE PARP-1 INHIBITOR NU1025 INCREASES GROWTH INHIBITORY EFFECTS OF TEMOZOLOMIDE AND TOPOTECAN IN P53 WILD-TYPE (D54) AND P53 MUTATED (U251) GLIOBLATSOMA CELLS.